The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Radiomic features quantifying pixel-level characteristics of breast tumors from magnetic resonance imaging predict risk factors in triple-negative breast cancer.
 
Adam B. Mantz
No Relationships to Disclose
 
Ryle Zhou
No Relationships to Disclose
 
Andrew Kozlov
No Relationships to Disclose
 
Wendy DeMartini
No Relationships to Disclose
 
Shu-Tian Chen
Speakers' Bureau - Siemens Healthcare Diagnostics
 
Satoko Okamoto
Consulting or Advisory Role - HOLOGIC
 
Debra M. Ikeda
Stock and Other Ownership Interests - Moderna Therapeutics; Pfizer
Consulting or Advisory Role - Hologic
 
Sarah A. Mattonen
No Relationships to Disclose
 
Sandy Napel
Consulting or Advisory Role - Fovia
Patents, Royalties, Other Intellectual Property - several patents, none currently licensed
 
Emel Alkim
No Relationships to Disclose
 
George W. Sledge
Leadership - Syndax; Tessa Therapeutics
Stock and Other Ownership Interests - Pionyr; Syndax; Tessa Therapeutics
Consulting or Advisory Role - AstraZeneca; Caris Life Sciences; G1 Therapeutics; GRAIL; Synaffix; Syndax; Verseau Therapeutics
Research Funding - Genentech/Roche (Inst); Pfizer (Inst); QED Therapeutics (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences; Tessa Therapeutics; Verseau Therapeutics
 
Allison W. Kurian
Research Funding - Myriad Genetics (Inst)
Other Relationship - Ambry Genetics; Color Genomics; GeneDx/BioReference; Genentech; InVitae
 
Mina Liu
No Relationships to Disclose
 
Melinda L. Telli
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; G1 Therapeutics; Genentech/Roche; Gilead Sciences; Guardant Health; Immunomedics; Merck; Natera; Novartis; OncoSec; Pfizer; Reflexion Medical; Sanofi
Research Funding - Abbvie (Inst); Bayer (Inst); Biothera (Inst); Calithera Biosciences (Inst); EMD Serono (Inst); Genentech (Inst); Medivation (Inst); Novartis (Inst); OncoSec (Inst); Pfizer (Inst); PharmaMar (Inst); Tesaro (Inst); Vertex (Inst)
Other Relationship - G1 Therapeutics; Immunomedics
 
Haruka Itakura
No Relationships to Disclose